iconstar paper   Hepatitis C Articles (HCV)  
Back grey arrow rt.gif
 
 
HCV Expanded Access Daclatasvir+Sofosbuvir in Europe
 
 
  Expanded access is currently available for this treatment.
Verified April 2014 by Bristol-Myers Squibb
 
Available A Multicenter Compassionate Use Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis C
 
First received: March 25, 2014
Last updated: April 16, 2014
Last verified: April 2014

  
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org